Global Medical REIT Inc.
Symbol: GMRE
NYSE
9.03
USDTrhová cena dnes
30.7150
Pomer P/E
0.5877
Pomer PEG
592.14M
MRK Cap
- 0.09%
Výnos DIV
Global Medical REIT Inc. (GMRE) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 7.4 | 4 | 7.2 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 33.7 | 8.2 | 6.2 | |||||||||||||
balance-sheet.row.inventory | 0 | -25.1 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | -41.1 | 18.3 | -50.3 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 14.4 | 30.5 | 24.9 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 7.6 | 3.5 | 3.8 | |||||||||||||
balance-sheet.row.goodwill | 0 | 5.9 | 5.9 | 5.9 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 66 | 148.1 | 127.9 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 71.9 | 154 | 133.8 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 1140.3 | -34.7 | -1.2 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8.5 | 1205.3 | 1100.9 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1253.3 | 1362.7 | 1238.5 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.account-payables | 0 | 12.8 | 13.8 | 10.3 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.4 | 636.4 | 514.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 610.8 | 57.7 | 57.2 | |||||||||||||
Deferred Revenue Non Current | 0 | 5.1 | 4.4 | 3.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 601.1 | 11.4 | 15.7 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 42.5 | 78.1 | 85.3 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 13 | 10.5 | 8.1 | |||||||||||||
balance-sheet.row.total-liab | 0 | 661.9 | 744.2 | 625.9 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 75 | 75 | 75 | |||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | -239 | -198.7 | -157 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 25.1 | 34.7 | -6.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 722.4 | 722 | 711.4 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 583.6 | 633 | 622.8 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1267.7 | 1393.3 | 1263.5 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 22.2 | 16.1 | 14.8 | |||||||||||||
balance-sheet.row.total-equity | 0 | 605.8 | 649.1 | 637.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 25.1 | 34.7 | 1.2 | |||||||||||||
balance-sheet.row.total-debt | 0 | 624.2 | 694.1 | 571.7 | |||||||||||||
balance-sheet.row.net-debt | 0 | 616.8 | 690.1 | 564.5 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 20.6 | 20 | 18.3 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 47.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -122.1 | 0 | -0.9 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | 4.2 | 4.7 | 5.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -5.7 | -1.7 | -3.8 | ||||||||||||
cash-flows.row.account-receivables | 0 | 0.4 | -3 | -0.7 | ||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.2 | ||||||||||||
cash-flows.row.account-payables | 0 | -2 | 4.1 | 1.9 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -4.1 | -2.8 | -5.3 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 113.3 | -4.1 | 2.2 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 2 | 2.8 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -2 | -2.8 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 86.1 | 11.1 | 4.4 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -1.3 | 7.8 | 2.6 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 74.8 | -137.3 | -194.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -86.1 | -16.7 | -232.2 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 9.9 | 205.5 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 221.6 | ||||||||||||
cash-flows.row.dividends-paid | 0 | -64.8 | -64.2 | -58.3 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 133.4 | -8.9 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -150.9 | 62.4 | 127.7 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -77.5 | 0 | 0 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -14.9 | 1.7 | 2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 7.4 | 14.5 | 12.8 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 22.3 | 12.8 | 10.8 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 68.4 | 76.5 | 69 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -10 | -156.2 | -201.7 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | 58.4 | -79.7 | -132.7 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 156.7 | 137.3 | 115.9 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 86.2 | 25.2 | 15.5 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 70.4 | 112.1 | 100.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 16.9 | 73.3 | 63.3 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 103.1 | 98.5 | 78.8 | ||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -16.9 | 56.7 | 46.9 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -31.8 | -18.8 | -18.8 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 46.5 | 25.2 | 19.7 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 58.1 | 57.7 | 46.9 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 53.5 | 38.8 | 37.1 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 21.7 | 20 | 18.3 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1.1 | 25.2 | 20.4 | ||||||||||||
income-statement-row.row.net-income | 0 | 20.6 | -5.2 | -2.1 |
Často kladené otázky
Čo je Global Medical REIT Inc. (GMRE) celkové aktíva?
Global Medical REIT Inc. (GMRE) celkové aktíva sú 1267700000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.759.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 0.891.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.134.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.345.
Aká je Global Medical REIT Inc. (GMRE) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 20612000.000.
Aký je celkový dlh firmy?
Celkový dlh je 624193000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 16897000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.